UTAH MEDICAL PRODUCTS, INC. Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2018-01-31)
UTAH MEDICAL PRODUCTS, INC. (UTMD) reported Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2018-01-31) of -$6.00 thousand for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-06.
Discontinued › Income Statement › Other Income
us-gaap:AvailableforsaleSecuritiesGrossUnrealizedGainLoss1 · last filed 2015-11-06
- UTAH MEDICAL PRODUCTS, INC. available-for-sale securities, gross unrealized gain (loss) (deprecated 2018-01-31) for the quarter ending 2015-09-30 was -$6.00K, a 220.00% decline year-over-year.
- UTAH MEDICAL PRODUCTS, INC. available-for-sale securities, gross unrealized gain (loss) (deprecated 2018-01-31) for the quarter ending 2015-06-30 was $4.00K.
- UTAH MEDICAL PRODUCTS, INC. available-for-sale securities, gross unrealized gain (loss) (deprecated 2018-01-31) for the quarter ending 2015-03-31 was -$2.00K.
- UTAH MEDICAL PRODUCTS, INC. available-for-sale securities, gross unrealized gain (loss) (deprecated 2018-01-31) for the quarter ending 2014-09-30 was $5.00K, a 400.00% increase year-over-year.
| Period end | Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2018-01-31) 3 month | Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2018-01-31) 6 month | Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2018-01-31) 9 month |
|---|---|---|---|
| 2015-09-30 | -$6.00K 10-Q · filed 2015-11-06 | -$2.00K derived: sum of 2 quarters · filed 2015-11-06 | -$4.00K derived: sum of 3 quarters · filed 2015-11-06 |
| 2015-06-30 | $4.00K 10-Q · filed 2015-08-07 | $2.00K derived: sum of 2 quarters · filed 2015-08-07 | |
| 2015-03-31 | -$2.00K 10-Q · filed 2015-05-06 | ||
| 2014-09-30 | $5.00K 10-Q · filed 2015-11-06 | $5.00K derived: sum of 2 quarters · filed 2015-11-06 | $0.00 derived: sum of 3 quarters · filed 2015-11-06 |
| 2014-06-30 | $0.00 10-Q · filed 2015-08-07 | -$5.00K derived: sum of 2 quarters · filed 2015-08-07 | |
| 2014-03-31 | -$5.00K 10-Q · filed 2015-05-06 | ||
| 2013-09-30 | $1.00K 10-Q · filed 2014-11-04 | $5.00K derived: sum of 2 quarters · filed 2014-11-04 | $10.00K derived: sum of 3 quarters · filed 2014-11-04 |
| 2013-06-30 | $4.00K 10-Q · filed 2014-08-08 | $9.00K derived: sum of 2 quarters · filed 2014-08-08 | |
| 2013-03-31 | $5.00K 10-Q · filed 2014-05-07 | ||
| 2012-09-30 | $8.00K 10-Q · filed 2013-11-06 | $0.00 derived: sum of 2 quarters · filed 2013-11-06 | |
| 2012-06-30 | -$8.00K 10-Q · filed 2013-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |